Skip to content

Clinical trials

Endocrine Gland Neoplasms trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Endocrine Gland Neoplasms Country / region: France Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20091
20111
20141
20152
20161
20173
20191
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Recruiting3
Active, not recruiting2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company2
Amgen1
Assistance Publique - Hôpitaux de Paris1
Celgene1
Central Hospital, Nancy, France1
Hoffmann-La Roche1
Hospices Civils de Lyon1
NantCell, Inc.1
Société Française d'Endoscopie Digestive1
Sumitomo Pharma America, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Endocrine Gland Neoplasms12
Neoplasms9
Endocrine System Diseases7
Neoplasms by Site7
Adenocarcinoma5
Carcinoma, Non-Small-Cell Lung5
Colonic Neoplasms5
Digestive System Neoplasms5
Head and Neck Neoplasms5
Lung Neoplasms5

Trials

Showing 26 to 12 of 12. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.